Clinicians

Down Syndrome Cannot Stay Outside Alzheimer’s Trials

Cataplexy Is Waiting on an FDA Clock

AstraZeneca’s heart drug failure raises a brutal question: how much treatment is too much treatment?

Beans for men, broccoli for women? The real cardiometabolic warning is that risk starts by 22

A Blood Test Will Not Fix Colorectal Screening by Itself

Radioligand Therapy Is Building Its Evidence Base. Now Build the Infrastructure.

Tau Is Back. Certainty Is Not.

Alzheimer’s Treatment Moves Home. Risk Does Not.

El Salvador Eliminated Trachoma. The Certificate Is Not The Finish Line.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
